Office of Extramural Research (OER)
The NIH Guide for Grants and Contracts is the official publication for NIH medical and behavioral research grant policies, guidelines and funding opportunities. Researchers can use this site to search for funding opportunities or sign up for weekly email updates on NIH-supported grants and contracts.
This section provides examples of current research activities and funding opportunities at the NIH, and is not intended to be a comprehensive list.
Located in the NIH Office of Disease Prevention (ODP), the Tobacco Regulatory Science Program coordinates the trans-NIH collaborative effort with the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support FDA’s regulatory authority for tobacco products. The TRSP website includes a research portfolio of grants and contracts carried over from prior fiscal years and new projects awarded in the current fiscal year. This website also provides a listing of funding opportunities that are currently accepting applications.
In October 2011, the Food and Drug Administration (FDA) and the NIH announced a joint national, prospective, longitudinal cohort study of tobacco users and those at risk for tobacco product use to monitor and assess the health impacts of their use. The PATH study represents the first large-scale NIH-FDA collaboration on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products under the Family Smoking Protection and Tobacco Control Act. Scientific experts at NIDA and FDA are coordinating this effort via a research contract awarded to Westat in Rockville, Maryland. The PATH study highlighted in the National Prevention Council Action Plan will prospectively follow almost 60,000 tobacco users age 12 and older at risk for tobacco product use in the United States. The study will (a) examine what makes people susceptible to tobacco product use; (b) evaluate initiation and use patterns, including the use of new products; (c) study patterns of tobacco product cessation and relapse; (d) evaluate the effects of regulatory changes on risk perceptions and other tobacco-related attitudes; and (e) assess differences in attitudes, behaviors, and key health outcomes among racial/ethnic, gender, and age subgroups. The PATH study also will collect biospecimens from adults to analyze biomarkers of tobacco use and disease processes.
Research to prevent and control tobacco use and tobacco-related cancers is a public health priority of the National Cancer Institute. The mission of the Tobacco Control Research Branch (TCRB) is to lead and collaborate on research, and to disseminate evidence-based findings to prevent, treat, and control tobacco use. Branch activities include: funding research grants and contracts, sponsoring conferences and symposia, and disseminating tobacco control science. Additionally, branch scientists conduct research and participate in diverse scientific and programmatic activities in support of national and international tobacco control efforts.
The International Tobacco and Health Research and Capacity Building Program aims to encourage trans-disciplinary research on the international tobacco epidemic and to reduce the global burden of morbidity and mortality caused by tobacco use. The program allows investigators in the U.S. and other high-income countries to gain expertise working under low- and middle-income-specific conditions. It also strengthens the research base of U.S. and foreign institutions, especially those institutions in low- and middle-income countries. To this end, capacity strengthening must be an integrated and significant part of the research proposal.
In addition to the funding opportunities listed above, NIH Institutes and Centers manage a wide variety of research-related grant programs. Below is a sampling of active funding opportunities.